Section
I: Pharmacologic Intervention
1. 1. Role of Platelet - Inhibitor Agents in
Coronary Artery Disease
2. Anticoagulants and Their Use in Acute Coronary
Syndromes and Coronary Interventions
3. Effects of Beta - Blockers, Calcium Channel
Blockers, Nitrates, and Magnesium in Acute Myocardial Infarction and
Unstable Angina Pectoris
4. Angiotensin - Converting Enzyme Inhibition and
Angiotensin Receptor Blockers and Extended on
5. Thrombolytic Intervention
6. Hypolipidemic Intervention and Prospects for
Regression
Section II: Coronary and Peripheral Intervention:
Key Applications
7. Percutaneous Coronary and Peripheral Intervention:
Historical Perspective
8. Elective Coronary Intervention: Indications,
Technique and Complications
9. Percutaneous Coronary Intervention for Unstable
angina
10. Complex Intervention
11. Efficacy of Percutaneous Coronary Intervention
12. Peri - Procedural Myocardial Infarction and
Emboli Protection
13. Abrupt Vessel Closure
14. Catheter - Based Reperfusion for acute
Myocardial Infarction
15. Chronic Total Occlusion
16. Percutaneous Intervention in Patients with Prior
Coronary Bypass Surgery
17. Ostial and bifurcation lesions
18. Long Lesions and Diffuse Disease
19. Inflammation and Arterial Injury
20. Animal Models of Human Coronary Restenosis
21. Restenosis: The Clinical Issues
22. Approach to Restotic Lesions
23. Surgical Standby for Percutaneous Intervention
24. Interventional Vascular Procedures in the
Peripheral, renal, Visceral and Extracranial Circulation
25. Coronary Atherectomy: Directional and Extraction
Techniques
26. Rotoblation
27. Stents: Technique and Adjunctive Therapy
28. Stents: The Menu
29. Stents: Indications and Limitations
30. Coated Stents and Local Drug Delivery for the
Prevention of Restenosis
31. Laser
32. Ultrasound Angioplasty
33. Radiation for Restenosis
34. Percutaneous Myocardial Revascularization
35. Angiogenesis
36. Percutaneous Bypass Surgery
37. Percutaneous Vascular Hemostatis Devices for
Arterial Sealing after Interventional Procedures
Section III: Bacterial, Protozoal and Arthropod
Infections
38. Interventional Approaches to the Introduction of
Genetic Material into the Cardiovascular System
39. Qualitative and Quantitative Angiography
40. Intracoronary Doppler and Pressure Monitoring
41. Percutaneous Coronary Angioscopy
42. Intravascular Ultrasound
Section IV: Valvuloplasty, Congenital and
Pericardial Heart Disease
43. Mitral Valvuloplasty
44. Advances in Percutaneous Aortic and Mitral
Valvuloplasty
45. Congenital Heart Disease
46. Percutaneous Balloon Percardiotomy for Patients
with Pericardial, Effusion and Tamponade
47. Catheter Based Treatment for Patients with
Hypertrophic Obstructive
Section V: Outcome Effectiveness of Interventional
Cardiology
48. Medical Economics and Interventional Cardiology
49. Quality of Care in Interventional Cardiology
50. Training, Credentialing and Guidelines
Section VI: Emerging Technologies
51. Device Genomics
52. Stem Cell Therapy for Ischemic Heart Disease
53. Detection of Vulnerable Plaque